Searched for
CONCORD BIO
Sensex rises! These stocks are up over 10% on BSEIn the Nifty 50 index, 24 stocks were trading in the green, while 26 stocks were trading in the red.- Sensex falls! But these stocks gained over 10% on BSEIn the Nifty 50 index, 23 stocks ended in the green, while 27 stocks closed in the red in today's trade.
- Constructive on markets, 2 stocks to buy now: Sudeep ShahSudeep Shah, from SBI Securities, predicts market consolidation and bullish movement towards 22,950-23,000. He further Recommends Aditya Bi...
- Lilly rides wave of weight-loss drug demand, working to expand capacityShares were off about 1% at $696.82 after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capit...
- ET MSME Awards 2023: Unveiling the nominees of India’s most comprehensive MSME awardsDiscover the comprehensive list of nominees contending for all 26 awards as part of the ET MSME Awards initiative. The winners for the ET M...
- Concord Biotech's niche API play holds promise for growthET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than ...
- Concord Bio's Rs 1,551-crore IPO to open on Aug 4The issue, which will close on August 8, is entirely an offer-for-sale, where the existing shareholder Helix Investments Holdings will sell...
- BSE-NSE bulk deals: Gannon Finance sells shares of Pritish Nandy CommunicationGannon Finance Investments sold 3 lakh shares of Pritish Nandy Communication of which 2,94,609 were picked by Indeas.com India at Rs 18.10 ...
- Covid-19 impact: The Silicon Valley workplace will never be the sameApple Inc. intends to stagger the introduction of employees back to the office, conduct temperature checks, keep people apart and create so...
- 2015 in review: Mergers and acquisitions peak in pharma industry; so does regulatory glareThe year also saw the government making an attempt to expand drugs under price control by revising the list of essential medicines.
- Mylan sells stake in Concord BiotechWorld’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...
Load More
